Posted by Michael Wonder on 29 Jun 2021
Neuros Medical receives FDA breakthrough device designation for its novel Altius high frequency nerve block system
29 June 2021 - Neuros Medical announced today that it has received Breakthrough Device Designation from the U.S. FDA for the use of its novel high frequency nerve block system as an aid in the management of chronic intractable pain of the lower limb of adult amputees.
Neuros anticipates completion of enrolment in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study by the fall of 2021.
